Chemomab Therapeutics Ltd DRC (CMMB) Insider Trading
- $60,300.00
- $1,886,452.00
- Jan. 3, 2023
- Neil Harris Cohen
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 3, 2023 | Major Shareholder | 336,900 | $3.58 | Sell | $1,206,102.00 | |
Nov. 16, 2022 | Director | 2,409 | $2.00 | Sell | $4,818.00 | |
Nov. 16, 2022 | Insider | 324,775 | $2.08 | Sell | $675,532.00 | |
March 18, 2022 | Director | 1,000 | $4.34 | Buy | $4,340.00 | |
March 14, 2022 | Director | 6,000 | $4.35 | Buy | $26,100.00 | |
March 14, 2022 | CFO | 1,250 | $4.04 | Buy | $5,050.00 | |
March 14, 2022 | CEO | 2,500 | $3.98 | Buy | $9,950.00 | |
Dec. 6, 2021 | Director | 2,000 | $7.43 | Buy | $14,860.00 |
Insiders are both buying and selling Chemomab Therapeutics Ltd DRC stock.
The insider traders at Chemomab Therapeutics Ltd DRC are: Neil Harris Cohen, Dale R Pfost, Donald Marvin, George Adi Mor, Israel Gp Ltd. Orbimed, and Joel Michael Maryles
The most active insider trader at Chemomab Therapeutics Ltd DRC is Neil Harris Cohen with 3 trades.
Israel Gp Ltd. Orbimed has sold the most Chemomab Therapeutics Ltd DRC stock with a total value of $2,412,204.00.
Neil Harris Cohen has bought the most Chemomab Therapeutics Ltd DRC stock with a total value of $67,060.00.
The most recent insider trade for Chemomab Therapeutics Ltd DRC was on Jan. 3, 2023.
The single biggest insider buy for Chemomab Therapeutics Ltd DRC was from Neil Harris Cohen with a total value of $26,100.00 on March 14, 2022.
The single biggest insider sell for Chemomab Therapeutics Ltd DRC was from Israel Gp Ltd. Orbimed with a total value of $1,206,102.00 on Jan. 3, 2023.